BEAT BioTherapeutics Corp — Form D
BEAT BioTherapeutics Corp of BELLEVUE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2013-04-16. The offering totals $2.5M, of which $2.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2013-04-16
- Form: D
- Accession: 0001574133-13-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $2.5M
- Amount sold: $2.4M
- Remaining: $100K
- Investors: 21
- Date of first sale: 2013-04-08
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-195092
Issuer
- Name: BEAT BioTherapeutics Corp
- CIK: 0001574133
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 1380 - 112TH AVE. NE, SUITE 200, BELLEVUE, WA, 98004
- Phone: (425) 269-3478
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Michael Kranda | Director | Bellevue, WA |
| Jim Leggett | Director | Bellevue, WA |
| Greg Mahairas, Ph.D. | Director | Bellevue, WA |
| Craig Tall | Director | Mercer Island, WA |
| Michael Kranda | Executive Officer | Bellevue, WA |
| Greg Mahairas, Ph.D. | Executive Officer | Bellevue, WA |
More